Crossmark

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients

Crossref DOI link: https://doi.org/10.1186/s12967-018-1427-5

Published Online: 2018-03-09

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lie, Mitchell R. K. L.

van der Giessen, Janine

Fuhler, Gwenny M.

de Lima, Alison

Peppelenbosch, Maikel P.

van der Ent, Cokkie

van der Woude, C. Janneke
License Information

Text and Data Mining valid from 2018-03-09
More Information

Article History

Received: 27 March 2017

Accepted: 27 February 2018

First Online: 9 March 2018